New print design for Arthritis Research & Therapy

Arthritis Research & Therapy is unveiling a new look in the latest print edition of the journal. This bi-monthly issue – now in its 11th volume – presents a compendium of content found on the journal website, where articles are continuously published.

The June print issue introduces a colourful new front cover design, and an Editors’ Choice page that highlights articles of special interest as selected by the Editors-in-Chief.  Subscribers will also receive a bumper edition of the journal containing six authoritative review articles on topics such as spondylarthritis, gout and systemic lupus erythematosus.

Arthritis Research & Therapy is an international, peer-reviewed journal with a focus in mechanisms of, and translational laboratory and clinical research into localised and systemic immune-inflammatory and degenerative diseases of the musculoskeletal system. The journal is edited by Professor Peter Lipsky and Professor Sir Ravinder N Maini with the support of an international Editorial Board.

All research articles published in Arthritis Research & Therapy are open access. Subscribers have unrestricted access to all commentaries and reviews, although all letters and editorials are freely available. A free 30-day online trial subscription is available via the website.

In 2008-9 the journal is marking 10 years of publication with its 10th anniversary issue – a collection of 39 reviews by renowned experts, providing both
researchers and clinicians with a comprehensive understanding of
current knowledge on the scientific basis of rheumatology, which is freely available online.

The journal also received a new, increased Impact Factor in June of 4.49, placing it amongst the top-ranked journals in rheumatology. Moreover, the broader and more informative 5-year Impact Factor places Arthritis Research & Therapy fourth in the field (4.64).

Abigail Jones
Senior Assistant Editor – Arthritis Research & Therapy

View the latest posts on the On Medicine homepage

Comments

By commenting, you’re agreeing to follow our community guidelines.

Your email address will not be published. Required fields are marked *